In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...
1d
Hosted on MSNCHOP doctors named 'Disruptors of the Year' for groundbreaking sickle cell gene therapyThe Philadelphia Citizen is recognizing CHOP doctors Alexis Thompson and Dr. Stephan Grupp with the 'Disruptors of the Year' ...
Sickle cell disease is a severe, inherited blood disorder that primarily affects people of African, Mediterranean, Middle Eastern, and Indian descent.Despite its widespread impact, SCD research has ...
Simmie White is taking control of her own story. The six-year-old girl and her mother want others to understand more about ...
As treatment and care continues to evolve, we must ensure that people living with this disease are able to advocate for ...
4don MSN
The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.
A new review and policy statement underscore the inaccuracy of sickle cell trait as a cause of death on autopsies.
A SYSTEMATIC review by the American Society of Hematology (ASH) has found no evidence to support sickle cell trait (SCT) as a cause of acute pain crises or sudden exertion-related death. This finding ...
In addition to the prolonged pain and suffering endured by sickle cell patients, a Washington University School of Medicine ...
This achievement follows Bahrain’s landmark decision on 2 December 2023 to become the second country globally and the first ...
3d
WCIV Charleston on MSNGene therapy among cutting-edge treatments at MUSC's new sickle cell center in CharlestonThe Medical University of South Carolina Health has established the Rena N. Grant Sickle Cell Center to help treat those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results